Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts

Clinical and Experimental Immunology

Volumn 132, Issue 2, 2003, Pages 239-246

  Miljkovic, Djordje ^a,b   Cvetkovic, I ^a   Stosic Grujicic, S ^a   Trajkovic, V ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Fibroblast; INOS IRF 1; Mycophenolic acid; Nitric oxide

Indexed keywords

GAMMA INTERFERON; ISOPROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYCOPHENOLIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; SEPIAPTERIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GRAFT REJECTION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNTHESIS;

ANIMALS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MYCOPHENOLIC ACID; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOPROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037541429     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02140.x     Document Type: Article

References (34)

1. Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000; 47:215-45.
2. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanism of action. Immunopharmacology 2000; 47:85-118.
3. Schiff M. Emerging treatments for rheumatoid arthritis. Am J Med 1997; 102:11-5.
4. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage fuction. Ann Rev Immunol 1997; 10:323-50.
5. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100:2407-13.
6. Senda M, Delustro B, Eugui E, Natsumeda Y. Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 1995; 60:1143-8.
7. Amin AR, Attur M, Abramson SB. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 1999; 11:202-9.
8. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996; 184:1519-24.
9. Schaffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997; 158:2375-81.
10. Witte MB, Thornton FJ, Efron DT, Barbul A. Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 2000; 4:572-82.
11. Romanska HM, Ikonen TS, Bishop AE, Morris RE, Polak JM. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease. J Pathol 2000; 191:71-7.
12. Pechold K, Patterson NB, Craighead N, Lee KP, June CH, Harlan DM. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. J Immunol 1997; 158:4921-9.
13. Trajkovic V, Stepanovic S, Samardzic T, Jankovic V, Badovinac V, Mostarica Stojkovic M. Cryptococcus neoformans neutralizes macrophage and astrocyte derived nitric oxide without interfering with inducible nitric oxide synthase induction or catalytic activity - possible involvement of nitric oxide consumption. Scand J Immunol 2000; 51:384-91.
14. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem, 1982; 126:131-8.
15. Versteeg HH, Nijhuis E, Van Den Brink GR, Evertzen M, Pynaert GN, Van Deventer SJ, Coffer PJ, Peppelenbosch MP. A new phospho-specific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 2000; 3:717-22.
16. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233:119-25.
17. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263:1612-5.
18. Miljkovic D, Samardzic T, Cvetkovic I, Mostarica Stojkovic M, Trajkovic V. Mycophenolic acid down-regulates inducible nitric oxide synthase induction in astrocytes. Glia 2002; 39:247-55.
19. Yu CC, Yang CW, Wu MS, Ko YC, Huang CT, Hong JJ, Huang CC. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice. J Laboratory Clin Med 2001; 138:69-77.
20. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 1999; 289:459-71.
21. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19:623-55.
22. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-60.
23. Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med 1996; 83:1447-59.
24. Wang Z, Brecher P. Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase. Hypertension 1999; 34:1259-64.
25. Jankovic V, Samardzic T, Stosic-Grujicic S, Popadic D, Trajkovic V. Cell-specific inhibition of inducible nitric oxide synthase activation by leflunomide. Cell Immunol 2000; 199:73-80.
26. Faure V, Hecquet C, Courtois Y, Goureau O. Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells. J Biol Chem 1999; 274:4794-800.
27. Varley CL, Dickson AJ. Hepatocyte isolation stimulates formation of interferon stimulatory response element DNA-protein complexes. Biochem Biophys Res Commun 1999; 263:627-31.
28. Vallee S, Fouchier F, Brauger D, Marvaldi J, Champion S. Ribavirin-induced resistance to heat shock, inhibition of the Ras-Raf-1 pathway and arrest in G(1). Eur J Pharmacol 2000; 404:49-62.
29. Caivano M. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 1998; 429:249-53.
30. Chan ED, Winston BW, Uh ST, Wynes MW, Rose DM, Riches DW. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. J Immunol 1999; 162:415-22.
31. Paul A, Cuenda A, Bryant CE, Murray J, Chilvers ER, Cohen P, Gould GW, Plevin R. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal 1999; 11:491-7.
32. Bogdan C. The multiplex function of nitric oxide in (auto) immunity. J Exp Med 1998; 187:1361-5.
33. Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol, 1995; 7:396-9.
34. Schoedon G, Schneemann M, Hofer S, Guerrero L, Blau N, Schaffner R. Regulation of the 1-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem 1993; 213:833-9.